Shalini Sharp
2015 - Ultragenyx Pharmaceutical
In 2015, Shalini Sharp earned a total compensation of $2.4M as Chief Financial Officer and Executive Vice President at Ultragenyx Pharmaceutical, a 365% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $182,700 |
|---|---|
| Option Awards | $1,378,004 |
| Salary | $420,000 |
| Stock Awards | $373,516 |
| Other | $28,082 |
| Total | $2,382,302 |
Sharp received $1.4M in option awards, accounting for 58% of the total pay in 2015.
Sharp also received $182.7K in non-equity incentive plan, $420K in salary, $373.5K in stock awards and $28.1K in other compensation.
Rankings
In 2015, Shalini Sharp's compensation ranked 4,023rd out of 13,638 executives tracked by ExecPay. In other words, Sharp earned more than 70.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,023 out of 13,638 | 71st |
Division Manufacturing | 1,466 out of 5,187 | 72nd |
Major group Chemicals And Allied Products | 535 out of 1,857 | 71st |
Industry group Drugs | 424 out of 1,531 | 72nd |
Industry Pharmaceutical Preparations | 334 out of 1,179 | 72nd |
Source: SEC filing on April 28, 2017.
Sharp's colleagues
We found five more compensation records of executives who worked with Shalini Sharp at Ultragenyx Pharmaceutical in 2015.
2015
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Operations Officer and Executive Vice President Analytical Sciences and Research
2015
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
2015
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2015
Dennis Huang
Ultragenyx Pharmaceutical
Chief Technical Operations Officer and Senior Vice President
2015
Thomas Kassberg
Ultragenyx Pharmaceutical